Literature DB >> 30363547

The Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease (CAPSIT-PD): Tolerability of Preoperative Neuropsychological Testing for Deep Brain Stimulation in Parkinson's Disease.

Gian D Pal1, Virginia Persinger1, Bryan Bernard1, Bichun Ouyang1, Christopher G Goetz1, Leo Verhagen Metman1.   

Abstract

OBJECTIVE: We examined tolerability of preoperative neuropsychological testing (the Core Assessment Program for Surgical Interventional Therapies in Parkinson's Disease [CAPSIT-PD] protocol) for DBS. We also examined factors that may influence tolerability, including fatigue, global cognitive function, depression, and patient-based characteristics.
METHODS: In this retrospective study, we reviewed preoperative neuropsychological testing results from 35 patients who were scheduled to undergo DBS. We examined the overall tolerability of the full battery and the tolerability of each test. We placed attention on a test's placement in the fixed order of the battery to measure whether there was a clustering of poorly tolerated tests toward the end of the battery as an indication of fatigue. Spearman's rank correlation was used to determine the relationship between tolerability and (1) global cognitive function, (2) depression, and (3) patient-based characteristics.
RESULTS: Fourteen subjects (40%) were able to tolerate the full battery and completed all 10 tests. The domains that were least tolerated pertained to executive function and procedural memory. There was a consistent time-based tolerability pattern that was observed. There was a significant correlation between tolerability and global cognitive function (ρ = 0.344; P = 0.043), but not depression (P = 0.197). There was a significant correlation between tolerability and age (ρ = -0.491; P = 0.003) and disease duration (ρ = -0.442; P = 0.008), but not UPDRS-III scores (P = 0.284).
CONCLUSION: Our results have shown limited tolerability of the full neuropsychological battery as outlined by the CAPSIT-PD protocol. We suggest the consideration of updating the neuropsychological assessment used in the CAPSIT-PD protocol.

Entities:  

Keywords:  CAPSIT; Parkinson's disease; cognition; deep brain stimulation

Year:  2015        PMID: 30363547      PMCID: PMC6178709          DOI: 10.1002/mdc3.12213

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  13 in total

Review 1.  Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD).

Authors:  G L Defer; H Widner; R M Marié; P Rémy; M Levivier
Journal:  Mov Disord       Date:  1999-07       Impact factor: 10.338

2.  Paced auditory serial addition test (PASAT): a very difficult test even for individuals with high intellectual capability.

Authors:  Joseph Bruno Bidin Brooks; Vinicius Oliveira Giraud; Youssef Jamal Saleh; Samuel Jose Rodrigues; Lucas Afonso Daia; Yara Dadalti Fragoso
Journal:  Arq Neuropsiquiatr       Date:  2011-06       Impact factor: 1.420

3.  Prevalence of fatigue in Parkinson disease and its clinical correlates.

Authors:  Fabrizio Stocchi; Giovanni Abbruzzese; Roberto Ceravolo; Pietro Cortelli; Marco D'Amelio; Maria F De Pandis; Giovanni Fabbrini; Claudio Pacchetti; Gianni Pezzoli; Alessandro Tessitore; Margherita Canesi; Claudio Iannacone; Mario Zappia
Journal:  Neurology       Date:  2014-06-13       Impact factor: 9.910

4.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  Diagnosing PD-MCI by MDS Task Force criteria: how many and which neuropsychological tests?

Authors:  Jennifer G Goldman; Samantha Holden; Bichun Ouyang; Bryan Bernard; Christopher G Goetz; Glenn T Stebbins
Journal:  Mov Disord       Date:  2014-12-01       Impact factor: 10.338

7.  Defining mild cognitive impairment: impact of varying decision criteria on neuropsychological diagnostic frequencies and correlates.

Authors:  John A Schinka; David A Loewenstein; Ashok Raj; Mike R Schoenberg; Jessica L Banko; Huntington Potter; Ranjan Duara
Journal:  Am J Geriatr Psychiatry       Date:  2010-08       Impact factor: 4.105

8.  Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.

Authors:  Aimee W Kao; Caroline A Racine; Lovingly C Quitania; Joel H Kramer; Chadwick W Christine; Bruce L Miller
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

9.  The association of apathy with central fatigue perception in patients with Parkinson's disease.

Authors:  Naia Sáez-Francàs; Jorge Hernández-Vara; Margarita Corominas Roso; José Alegre Martín; Miguel Casas Brugué
Journal:  Behav Neurosci       Date:  2013-01-21       Impact factor: 1.912

10.  Deep brain stimulation and the role of the neuropsychologist.

Authors:  Michael S Okun; Ramon L Rodriguez; Ania Mikos; Kimberly Miller; Ida Kellison; Lindsey Kirsch-Darrow; Dylan P Wint; Utaka Springer; Hubert H Fernandez; Kelly D Foote; Gregory Crucian; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2007-01       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.